• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前睫状肌麻痹验光在LASIK治疗远视中的作用。

Role of preoperative cycloplegic refraction in LASIK treatment of hyperopia.

作者信息

Frings Andreas, Steinberg Johannes, Druchkiv Vasyl, Linke Stephan J, Katz Toam

机构信息

Department of Ophthalmology, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1399-404. doi: 10.1007/s00417-016-3308-z. Epub 2016 Mar 3.

DOI:10.1007/s00417-016-3308-z
PMID:26935202
Abstract

BACKGROUND

Previous studies have suggested that, to improve refractive predictability in hyperopic LASIK treatments, preoperative cycloplegic or manifest refraction, or a combination of both, could be used in the laser nomogram. We set out to investigate (1) the prevalence of a high difference between manifest and cycloplegic spherical equivalent in hyperopic eyes preoperatively, and (2) the related predictability of postoperative keratometry.

METHODS

Retrospective cross-sectional data analysis of consecutive treated 186 eyes from 186 consecutive hyperopic patients (mean age 42 [±12] years) were analyzed. Excimer ablation for all eyes was performed using a mechanical microkeratome (SBK, Moria, France) and an Allegretto excimer laser platform. Two groups were defined according to the difference between manifest and cycloplegic spherical equivalent which was defined as ≥1.00 diopter (D); the data was analyzed according to refractive outcome in terms of refractive predictability, efficacy, and safety.

RESULTS

In 24 eyes (13 %), a preoperative difference of ≥1.00D between manifest spherical equivalent and cycloplegic spherical equivalent (= MCD) occurred. With increasing preoperative MCD, the postoperative achieved spherical equivalent showed hyperopic regression after 3 months. There was no statistically significant effect of age (accommodation) or optical zone size on the achieved spherical equivalent.

CONCLUSIONS

A difference of ≥1.00D occurs in about 13 % of hyperopia cases. We suggest that hyperopic correction should be based on the manifest spherical equivalent in eyes with preoperative MCD <1.00D. If the preoperative MCD is ≥1.00D, treatment may produce manifest undercorrection, and therefore we advise that the patient should be warrned about lower predictability, and suggest basing conclusions on the arithmetic mean calculated from the preoperative manifest and cycloplegic spheres.

摘要

背景

以往研究表明,为提高远视性准分子激光原位角膜磨镶术(LASIK)治疗的屈光预测性,可在激光验光程序中使用术前睫状肌麻痹验光或显验光,或两者结合。我们旨在研究(1)远视眼术前显验光和睫状肌麻痹验光的等效球镜度数差异较大的发生率,以及(2)术后角膜曲率测量的相关预测性。

方法

对连续186例远视患者(平均年龄42[±12]岁)的186只连续治疗眼进行回顾性横断面数据分析。所有眼睛均使用机械微型角膜刀(法国Moria公司的SBK)和Allegretto准分子激光平台进行准分子消融。根据显验光和睫状肌麻痹验光的等效球镜度数差异定义为≥1.00屈光度(D)分为两组;根据屈光预测性、有效性和安全性方面的屈光结果对数据进行分析。

结果

24只眼(13%)术前显验光等效球镜度数与睫状肌麻痹验光等效球镜度数之间的差异≥1.00D(=MCD)。随着术前MCD的增加,术后3个月时等效球镜度数出现远视性回退。年龄(调节)或光学区大小对术后等效球镜度数无统计学显著影响。

结论

约13%的远视病例存在≥1.00D的差异。我们建议,对于术前MCD<1.00D的眼睛,远视矫正应基于显验光等效球镜度数。如果术前MCD≥1.00D,治疗可能会导致明显的欠矫,因此我们建议应告知患者预测性较低,并建议根据术前显验光和睫状肌麻痹验光球镜度数计算的算术平均值得出结论。

相似文献

1
Role of preoperative cycloplegic refraction in LASIK treatment of hyperopia.术前睫状肌麻痹验光在LASIK治疗远视中的作用。
Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1399-404. doi: 10.1007/s00417-016-3308-z. Epub 2016 Mar 3.
2
Hyperopic laser in situ keratomileusis: primary and secondary treatments are safe and effective.远视性准分子原位角膜磨镶术:初次和二次治疗均安全有效。
Cornea. 2001 May;20(4):388-93. doi: 10.1097/00003226-200105000-00010.
3
Laser in situ keratomileusis for hyperopia and hyperopic astigmatism with the Nidek EC-5000 Excimer laser.
J Refract Surg. 2001 Nov-Dec;17(6):670-5. doi: 10.3928/1081-597X-20011101-06.
4
Outcomes of retreatment after hyperopic laser in situ keratomileusis.远视激光原位角膜磨镶术后的治疗结果。
J Cataract Refract Surg. 2017 Nov;43(11):1436-1442. doi: 10.1016/j.jcrs.2017.08.014.
5
LASIK correction of spherical hyperopia, hyperopic astigmatism, and mixed astigmatism with the LADARVision excimer laser system.使用LADARVision准分子激光系统对球面远视、远视散光和混合散光进行准分子原位角膜磨镶术(LASIK)矫正。
Ophthalmology. 2002 Sep;109(9):1647-56; discussion 1657-8. doi: 10.1016/s0161-6420(02)01133-8.
6
Accuracy of refractive outcomes in myopic and hyperopic laser in situ keratomileusis: Manifest versus aberrometric refraction.近视和远视激光原位角膜磨镶术的屈光结果准确性:主观验光与像差验光。
J Cataract Refract Surg. 2012 Nov;38(11):1989-95. doi: 10.1016/j.jcrs.2012.05.045.
7
Laser in situ keratomileusis for the correction of hyperopia from +1.25 to +5.00 diopters with the Technolas Keracor 117C laser.使用Technolas Keracor 117C激光进行准分子原位角膜磨镶术矫正1.25至5.00屈光度的远视。
J Refract Surg. 2001 Mar-Apr;17(2):113-22. doi: 10.3928/1081-597X-20010301-04.
8
Six-Month Outcomes After High Hyperopia Correction Using Laser-Assisted In Situ Keratomileusis With a Large Ablation Zone.使用大消融区准分子原位角膜磨镶术矫正高度远视后的六个月结果
Cornea. 2019 Sep;38(9):1147-1153. doi: 10.1097/ICO.0000000000002011.
9
5-year follow-up of LASIK for hyperopia.远视性准分子激光原位角膜磨镶术的5年随访
Ophthalmology. 2005 Feb;112(2):191-9. doi: 10.1016/j.ophtha.2004.09.017.
10
[Safety of the automated microkeratome for Sub-Bowman's Keratomileusis on the flat cornea].[自动微型角膜刀在扁平角膜上进行角膜基质层下准分子原位角膜磨镶术的安全性]
J Fr Ophtalmol. 2016 Feb;39(2):202-9. doi: 10.1016/j.jfo.2015.07.004. Epub 2015 Nov 6.

引用本文的文献

1
Twelve-month outcomes of single-step transepithelial photorefractive keratectomy for moderate hyperopia and hyperopic astigmatism.单步经上皮光屈光性角膜切削术治疗中度远视和远视散光的12个月疗效
Eye Vis (Lond). 2023 Mar 1;10(1):7. doi: 10.1186/s40662-023-00327-4.
2
Comparative evaluation of visual outcomes and corneal asphericity after laser-assisted in situ keratomileusis with the six-dimension Amaris excimer laser system.使用六维阿玛里斯准分子激光系统进行准分子原位角膜磨镶术后视觉效果和角膜非球面性的比较评估。
PLoS One. 2017 Feb 10;12(2):e0171851. doi: 10.1371/journal.pone.0171851. eCollection 2017.

本文引用的文献

1
Screening of refractive surgery candidates for LASIK and PRK.对接受准分子激光原位角膜磨镶术(LASIK)和准分子激光角膜切削术(PRK)的屈光手术候选者进行筛查。
Cornea. 2014 Oct;33(10):1051-5. doi: 10.1097/ICO.0000000000000171.
2
Adjuvant corneal crosslinking to prevent hyperopic LASIK regression.辅助性角膜交联术预防远视性准分子激光原位角膜磨镶术(LASIK)术后回退
Clin Ophthalmol. 2013;7:637-41. doi: 10.2147/OPTH.S39796. Epub 2013 Mar 31.
3
One-year results of excimer laser in situ keratomileusis for hyperopia.准分子激光原位角膜磨镶术治疗远视的一年期结果。
J Cataract Refract Surg. 2009 Jul;35(7):1156-65. doi: 10.1016/j.jcrs.2009.03.014.
4
Laser in situ keratomileusis for spherical hyperopia and hyperopic astigmatism using the NIDEK EC-5000 excimer laser.使用NIDEK EC-5000准分子激光进行的准分子原位角膜磨镶术治疗球面远视和远视散光。
J Refract Surg. 2008 Feb;24(2):123-36. doi: 10.3928/1081597X-20080201-02.
5
Hyperopic LASIK with Esiris/Schwind technology.采用艾西丽斯/施温德技术的远视性准分子原位角膜磨镶术
J Refract Surg. 2006 Oct;22(8):772-81. doi: 10.3928/1081-597X-20061001-07.
6
Photorefractive keratectomy and LASIK for the correction of hyperopia: 2-year follow-up.准分子激光角膜切削术和准分子原位角膜磨镶术矫正远视:2年随访
J Refract Surg. 2006 Feb;22(2):131-6. doi: 10.3928/1081-597X-20060201-09.
7
Five techniques for improving outcomes of hyperopic LASIK.改善远视性准分子激光原位角膜磨镶术效果的五种技术。
J Refract Surg. 2005 Sep-Oct;21(5 Suppl):S628-32. doi: 10.3928/1081-597X-20050902-14.
8
Corneal asphericity change after excimer laser hyperopic surgery: theoretical effects on corneal profiles and corresponding Zernike expansions.准分子激光远视手术后角膜非球面性变化:对角膜形态及相应泽尼克展开式的理论影响
Invest Ophthalmol Vis Sci. 2004 May;45(5):1349-59. doi: 10.1167/iovs.03-0753.
9
Wavefront-optimized ablation profiles: theoretical background.波前优化消融轮廓:理论背景
J Cataract Refract Surg. 2004 Apr;30(4):775-85. doi: 10.1016/j.jcrs.2004.01.026.
10
Long-term evaluation of hyperopic laser in situ keratomileusis.远视性准分子原位角膜磨镶术的长期评估
J Cataract Refract Surg. 2003 Nov;29(11):2181-8. doi: 10.1016/s0886-3350(03)00416-4.